Stay updated on Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Sign up to get notified when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.

Latest updates to the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page
- CheckyesterdayChange DetectedAdded a site-wide notice about lapse in government funding and operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check8 days agoChange DetectedAdded a glossary toggle and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and a new footer revision 'v3.4.0'. Also adjusted capitalization and wording of related items (e.g., 'met QC Criteria' vs 'Met QC Criteria', 'data' vs 'Data'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedVersion metadata updated from v3.3.3 to v3.3.4; no changes to study content or visible page details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded a consolidated Locations section listing all participating states. Removed separate per-state location sections and the HHS Vulnerability Disclosure link.SummaryDifference1%

- Check72 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no user-visible changes to the study details or page layout were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedDeletion of the government funding notice about potential delays in website updates and responses. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Tempol (MBM-02) in COVID-19 Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tempol (MBM-02) in COVID-19 Patients Clinical Trial page.